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Abstract  
Title: What Contributes To Lack Of Hypertension Awareness In An Urban 
Population? 
Author: Tara Mhedin 
Cardiovascular diseases (CVD) are responsible for the largest proportion of non-
communicable disease (NCD) related deaths below the age of 70 years. This primarily 
includes conditions caused by high blood pressure (BP), which is a major health 
implication within our ageing society.  
Nations have implemented cost-efficient and applicable interventions, with success rates 
in improving public health (PH) and reducing BP, with implemented goals and action 
plan-programs; including comprehensive primary prevention for management over the 
last few decades; both pharmacologically and lifestyle changes.  
There is an increase in awareness from the early 2000s till today. Improvements 
regarding awareness have occurred in urban population, as a result of programs 
implemented for primary prevention. But the numbers are far from optimal as high rates 
of morbidity and mortality of the diseases caused by hypertension (HPT) still contributes 
to the leading cause of CVD´s. Prevalence of HPT is still high as population is growing, 
aging, and urbanization and globalization of unhealthy lifestyles increasing.  
Increased prevalence of HPT and the fact that the ’rule of halves’ still is valid in many 
urban populations, with still high numbers of unawareness, shows we still have not yet 
reached our goal of increasing awareness and decreasing uncontrolled HPT. 
Amassed public knowledge and education by primary prevention intervention policies. 
Therefore, we still need improvements in screening criteria’s and diagnostic protocols, 
education, and finally, adequate treatment.  
 
Key words:  Hypertension, Awareness, Primary prevention. 
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Sažetak 
Naslov: Uzroci Neznanja o Postojanju Viskog Krvnog Tlak u Urban Populaciji 
Autor: Tara Mhedin 
Kardiovaskularne bolesti kao nezarazne bolesti glavni su uzrok smrtnosti osoba mlađih 
od 70 godina. Primarno uključuju stanja i bolesti uzrokovane visokim krvnim tlakom, što 
je važna zdravstvena implikacija u našem društvu koje stari. Mnoge nacije su 
implementirale novčano isplative i primjenjive intervencije koje su pokazale uspjeh u 
smanjenju krvnog tlaka i u poboljšanju javnog zdravstva. Tijekom posljednjih nekoliko 
desetljeća provedeni su programi i ciljevi akcijskog plana uključujući sveobuhvatnu 
primarnu prevenciju, farmakološki pristup i promjenu načina života.  
Od ranih 2000-ih do danas cjelokupna populacija svjesnija je problema. Najveći pomak 
se odvio u urbanoj populaciji kao rezultat implementiranog programa za primarnu 
prevenciju. No, brojke su daleko od optimalnih, jer visoke stope morbiditeta i mortaliteta 
uzrokovane hipertenzijom i dalje pridonose vodećom uzroku kardiovaskularnih bolesti. 
Kako populacija brojčano raste, stari, a urbanizacija i globalizacija su kao nezdravi načini 
života u porastu, tako raste i rasprostranjenost visokog krvnog tlaka.    
Povećana rasprostranjenost visokog krvnog tlaka i činjenica da je “pravilo polovica” i 
dalje važeće u urbanim sredinama, s još uvijek visokim brojem neinformiranih ljudi 
pokazuje nam da još uvijek nismo dostigli cilj o povećanju svjesnosti i smanjenju 
nekontrolirane hipertenzije.     
Prikupljeno javno znanje i edukacija kroz primarnu preventivnu intervencijsku politiku 
pokazalo se uspješnim, ali su nam još uvijek potrebna dodatna poboljšanja kriterija za 
trijažu, te poboljšanja dijagnostičkih protokola, edukacije i odgovarajućeg liječenja. 
 
Ključne riječi:  Hipertenzija, svjesnost, primarna prevencija.  
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1.0 Introduction  
NCD´s today have become today’s world leading cause of morbidity and mortality due to 
numerous factors, such as: growing urbanization, an aging population, increased income 
and globalization of increasing sedentary lifestyles and smoking and unhealthy diet [1,2]. 
HPT and its burden (effect mostly populations in low- and middle-income countries, 
where health systems and education systems are weaker) is perhaps the most significant 
risk factor for CVD´s, (which is the number one cause of death) accounting for 45% of 
all heart disease-related deaths and 51% of deaths due to stroke [1,2,3]. 
HPT is however becoming a worldwide epidemic, even in high-income countries, as one 
of the leading behavioral risk factors to which 13% of the global deaths are attributed 
[1,2,3]. HPT, the primary cause of almost half of all ischemic heart diseases and strokes, 
also contributes to the development of hemorrhagic stroke, kidney failure, premature 
death and disability and metabolic syndrome [3,4]. HPT causes about 7.5-9.5 million 
deaths every year and accounts for 57 million disability adjusted life years (DALY) [5]. 
The ’rule of halves’ although decreasing, is still valid in some urban populations [6], 
although the Asian-Indian paradox referring to high prevalence of heart diseases despite 
lower presence of the traditional risk factors also contributes to the high prevalence in 
those areas [7]. Primary health care (PHC) level is one affordable way to tackle today’s 
urban HPT unawareness [8,9,10]. Collaboration between PHC and PH is seen as one 
strategy to address the principles of equity and access in health care (HC) and to meet the 
goals of “health for all” [11] as outlined in the Alma Ata Declaration.  
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1.1 Definition  
Normal adult BP is defined as a systolic blood pressure (SBP) of 120 mm Hg and a 
diastolic blood pressure (DBP) of 80 mm Hg [12]. HPT is defined as a SBP of 140 mm 
Hg or more, or a DBP of 90 mm Hg or more, or taking antihypertensive medication [12].  
HPT may be primary or secondary [13]. Depending on the cause, primary or essential 
HPT, which accounts for 90-95% of adult cases, develop as a result of environmental or 
genetic causes [13]. Secondary HPT has multiple etiologies, including renal, vascular, 
and endocrine causes [13].  
 
1.2 Pathophysiology 
In the majority of cases, there is no known cause for primary HPT [14]. In general terms, 
the harder the heart has to work in order to pump blood when the pressure in the blood 
vessels is higher [14]. Uncontrolled, HPT can lead to a heart attack, an enlargement of the 
heart and eventually heart failure [15]. The high BP in the blood vessels may lead to 
aneurysms causing them to clog, burst and cause blood to leak out into the brain causing 
a stroke [14]. HPT can also lead to kidney failure, blindness, rupture of blood vessels and 
cognitive impairment [14] and contributes to metabolic syndrome [4]. 
According to the WHO; the main Factors that contribute to the development of high 
blood pressure and its complications are [2]; Social determinants and drivers 
(globalization, urbanization, aging, education, income, housing) determining behavioral 
risk factors (unhealthy diet, tobacco use, physical inactivity and harmful use of drugs) 
that can increase the metabolic risk factors (High BP, obesity, diabetes, increased blood 
lipids) leading to CVD´s. 
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1.3 Risk Factors 
CVD´s are caused by many risk factors. Some are non-modifiable while some can be 
modified, treated and controlled. 
The non-modifiable risk factors for HPT according to the World Heart Federation [15]: 
 
Age 
The probability of CVD´s increases with advancing age. Physiological changes of the 
heart, comes with increasing age, even in the absence of disease. Stiffening of cardiac 
muscle causes a less efficient pumping of blood from the heart to the rest of the 
circulation. 
 
Gender 
The male sex is at greater risk of CVD´s than a pre-menopausal woman. Post-menopausal 
women have lost the protective effects of estrogen and have the same risks as a man. 
 
Family history 
A positive history of first-degree blood relative before the age of 55 years (for a male 
relative) or 65 years (for a female relative) increases the risk of CVD development. 
Modifiable risk factors for HPT according to the World Heart Federation [15]: 
HPT, smoking, hyperglycemia, physical inactivity, unhealthy diet, high cholesterol and 
lipids, overweight and obesity; increases the chances of HPT and CVD´s [15,16]. 
Changing or reducing risk factors for high BP can reduce the chances of CVD´s. Patients 
should be encouraged to reduce factors contributing to CVD´s.  
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According to the WHO global health observatory data, the risk factors for CVD´s, 
doubles for each increased increment of 20/10 mmHg of BP starting as low as 115/75 
mm Hg [16], with more than a twofold difference increased risk in CVD´s with BP 130-
139/85-89 when compared with BP 120/80 [17]. According to Framingham study 
population research, it is also important to distinguish between usual or average BP from 
normal or acceptable, which is the optimal one for avoiding the HPT related CVD´s [18]. 
 
1.4 Symptoms of hypertension 
This “invincible” disease rarely causes symptoms in early stages [2,5,14]. Once 
symptoms develop, it usually is a sign of organ damage and urgent treatment is needed. 
Symptoms when present can be headache, shortness of breath, dizziness, chest pain, 
palpitations of the heart and nose bleeds [2,5,12,14].  
 
1.5 How to properly diagnose hypertension 
Many tests are available in the evaluation of HPT. Critical approaches to laboratory and 
radiologic evaluation can avoid unnecessary expenses [19]. A proper evaluation involves 
performing a focused medical history and physical examination, accurate BP measuring, 
and results of routine laboratory studies including a 12-lead electrocardiogram [19]. 
Needed material for measurements: 
There are electronic, mercury and aneroid devices that are used to measure BP. It is 
recommended to use electronic devices, given that mercury is toxic [18]. 
Hypertension workup primarily involves accurate BP measurement, a focused medical 
history, physical examination and a routine laboratory workup [20].  
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Accurately measuring the patient’s BP [18,19,20]. 
1. Sitting quietly for 3-5 min 
2. Inflate cuff 20-30 mmHg above loss of radial pulse 
3. Deflate at 2 mmHg/second 
4. 1st sound heard is SBP 
5. Disappearance 2nd sound/ Korotkoff sound (phase5) is DBP 
To confirm HPT, workup procedure should to be repeated about 2 months later for stage 
1 and shorter if it is a new onset HPT or for higher stages. Further studies may be 
obtained if needed on basis of clinical findings and/or suspected secondary hypertension 
with evidence of end-organ damage [13]. Patients presenting with HPT should have a 
cardiovascular risk assessment, including tests for diabetes mellitus and other risk factors 
such using the risk prediction chart [21].  
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2.0 Epidemiological data on hypertension  
 
2.1 Epidemiological data of hypertension prevalence  
It is estimated that HPT causes about 7.5 million deaths every year and accounts for 
approximately 57 million DALYs [16]. National Health and Nutrition Examination 
Survey (NHANES) data through 1991, suggested that HPT prevalence was declining 
[22], while other reports indicate that people diagnosed with HPT has been increasing 
from 600 million in 1980 to 972 million people in 2000 [16,23]. This was more than 25% 
of the whole worlds population at that time. The prevalence of raised BP in adults aged 
25 and over was around 40% in 2008 [16], and predicted to increase to 1.56 billion 
people by 2025, with the majority being in developing continents such as Africa and Asia 
[23,24]. This situation is starting to resemble the one observed in industrialized countries 
20 years ago.   
High prevalence and low control of HPT is attributed to factors [2,5,14] such as: 
 population growth,  
 ageing   
 behavioral risk factors, such as increased average salary, unhealthy diet, harmful 
use of alcohol, lack of physical activity, excess weight and exposure to persistent 
stress (contributing to the negative effects of rapid urbanization) 
 
 
2.2 Epidemiological data of uncontrolled hypertension 
According to the center for disease control (CDC), more people with high BP (especially 
those 60 years or older) are aware of their condition today and receiving treatment for it 
[25].  
Unfortunately, uncontrolled HPT is still high. Only about half of people with high BP 
have their condition controlled as data indicated that more then half of the patients 
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referred for a cardiac stress test had inadequate control and nearly one quarter had a BP 
above 160/100 mm Hg  [26].  
The aim of a study in England from May 2010 to July 2012 was to identify the 
characteristics of individuals who where missed by the general health check-ups with 
HPT without a previous history of CVD´s in the general population. Out of 8933 
hypertensive participants in the study, 408 where under no treatment [27]. Due to the fact 
that HPT is a ‘hidden’ disease, it was more likely to be diagnosed with more frequent 
consultations. The same study also concluded an association between patients with 
untreated HPT and living alone [27]. 
There seems to have been a slight decrease of uncontrolled HPT between the years of 
1980 and 2008. However, due to growth and aging of the population, there is still a high 
prevalence of uncontrolled HPT [2,5]. 
As the cornerstones of primary prevention programs for CVD´s has been population-
based approaches and intensive targeted strategies in PH by policies and guidelines [28], 
However reports show that even once diagnosed with HPT, many do not receive adequate 
BP lowering treatment for it to reach optimal levels [29].  
 
2.3 Epidemiological data and contributions to unawareness 
Population-based cross-sectional studies in low and middle income countries in Africa, 
Asia and south America showed that HPT awareness and treatment among those who 
were aware, widely varied between communities, and there is a clear need to focus on 
primary preventions [30]. Awareness levels differed from 33.5% in India to 69% in Peru 
[30]. HPT is one major modifiable risk factor for CVD´s and provides a powerful basis 
for preventing CVD complications [30]. Yet not handled very efficiently. 
Primary prevention of HPT; promotes, interrupts and prevents the continuous costly cycle 
of its management [30]. Applying complementary strategies targeting a population- level, 
an individual-level and high-risk groups for HPT, has been a very successful way to 
decrease the absolute risk for HPT (even small decrement in SBP result in considerable 
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reduction of BP-related diseases) [30]. These strategies applied early in life provides the 
greatest long term potential for avoiding the HPT precursors [30].  
However even with efficient interventions in improving PH and despite precise 
guidelines for the detection and prevention of HPT, recent studies have shown that 
awareness is far from optimal as the “rule of haves” still apply in some urban areas [6].  
The “rule of halves” was first published in a classic paper by Wilber et al. [31]; 
observing: 
1. only one half of the patients with high BP have been diagnosed, 
2. only half of those detected have been treated, 
3. only half of those treated are on adequate treatment to reach a normal BP  
 
 
 
Chart 2: Rule of halves by Wilber and Barrow [31]: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660552/ 
 
A study in Japan on HPT awareness from the national health survey in 1990s showed that 
more than 50% of men with HPT were unaware that they had high BP and less than 5% 
were under treatment [31]. The employed Canadian guidelines and criteria’s of 
hypertension in Japan in 1990 was: A BP of 160/95 mmHg or being on medical treatment 
for hypertension, while the US had a stricter HPT criteria. Differences in guidelines may 
50,0% 
25,0% 
12,5% 
12,5% 
not detected 
detected but not 
treated 
well treated 
poorly treated 
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be attributed to the low awareness. The prevalence of SBP in Japan has decreased in all 
groups of men and women, but still high in people above 50 years of age [32].  
Low rates of HPT treatment and control were the main causes of the high first-ever stroke 
incidence in China [33]. Women, a positive family history of HPT, obesity, diabetics and 
patients that suffered from a previous heart disease or stroke were less likely to be 
unaware of their hypertensive condition. During 2001-2010, the awareness of HPT in 
China increased from 69.8% to 74.5% in an urban elderly population [34]. A higher 
awareness of HPT was noted in higher educational levels, a higher BMI and positive 
family history of HPT. 
In an urban population of Kerala (South India) in 2009, 33% of the hypertensive 
individuals were unaware of their condition [35]. Here the awareness was higher among 
the older population and low among the young. This could be explained by the popular 
belief that HPT only occurs in the elderly, with associated diabetes and the complete   
unawareness in the pre-hypertensive group about the needed and/or beneficial modifiable 
risk factors. 
The general HPT awareness in Greece is very low compared the other western countries 
which strongly was associated with inadequate aspects of the HC systems today [36], 
again highlighting the importance of good prevention programs. 
A cross sectional study conducted in a central city in Iran between 2005 and 2006 
showing an increase in awareness, although still less then half of the hypertensive people 
being aware of their condition [37].   
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3.0 Discussion 
NCD´s is a global PH epidemic in the 21 century, with CVD´s accounting for the 
majority of them and HPT being the leading risk factor for CVD´s, causing 57 million 
DALYs [1,2,3,5]. 
The number of people diagnosed with HPT rose from being less then a million in 1980 to 
more than a billion in 2008 with a predicted increase to almost 1.6 billion by 2025 
[16,23], with 75% being in low and middle income countries like the Asian African 
continents [24].  
There is a rapid urbanization in China and India since 2014, with an expected additional 
increase of 292 million and 404 million people respectively by 2050 [38]. With the 
negative effects of rapid urbanization (which correlates with globalization of increasing 
sedentary lifestyles and smoking and the aging of population [1,2,5]), HPT and the 
treatment and control should urgently be recognized as a top priority in prevention and 
HC.  
Governments today are overwhelmed and not able to keep up with the accelerating 
burden of NCD´s [2]. It is clear that the financial burden will reach levels beyond the 
capacity of even wealthy countries to manage regarding this invincible killer. So the 
problem does not only lie in low- and middle-income countries.  
HPT rarely causes symptoms in its early stages and is a “hidden” disease [2]. 
Misconceptions could be due to the terms “benign” or “essential” HPT (almost indicating 
that HPT is normal or even necessary with old age) or in criteria’s with higher levels of 
BP to be considered as HPT. Therefore criteria’s applied should be universally equal and 
maybe even stricter definitions and guidelines is required. Misbelieves about the 
condition of HPT only existing in elderly, the absolute involvement of other diseases 
(like diabetes) and that HPT always presents with symptoms [35], seems to be common. 
And therefore many people may go undiagnosed for a long time, allowing the worsening 
of the condition and following organ damage. 
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The rule of halves, are decreasing but proven to still exist and therefore still be valid in 
some urban population [6]. Despite global efforts to tackle the challenge of NCD´s the 
evolution of HPT rates are increasing [16,23,24].  
Among untreated hypertensive subjects (which partially was due to unawareness) there 
was a significant association with; the male sex, age (<45 but below 60), less frequent 
visits to a health care provider (HCP) and general practitioner (GP) [39], dissatisfaction 
with recent medical care, high total cholesterol and lower body weights also lead to 
unawareness. 
It is very understandable that people having dissatisfaction with medical care are less 
likely to back to for other medical advice, care or treatment. This emphasizes the 
importance of having ethical values when working in medicine and doctor-patient 
communication [40].  
Has information not been adequate or the delivery of it from physicians? Is the 
information too expensive or has the disease been underestimated?  
Despite abundant evidence demonstrating that CVD´s and HPT can be prevented (by 
changing lifestyle behaviors and decreasing metabolic and physiological risk factors) 
many policy-makers still fail to consider NCD´s as a global or national health priority 
[24]. Effective interventions such as tobacco control measures and salt reduction are 
available and abundant in many countries, but lacking adequate commitment [24].  
The situation in developing countries is starting to resemble the one observed in 
industrialized countries 20 years ago and should alert serious concerns, considerations 
and commitments on all levels to preventing this growing epidemic.  
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4.0 Conclusion  
HPT, the most significant risk factor for CVD´s has been on a rise since the 1980s. This 
“Invincible killer” is predicted to increase to around 1.6 billion by 2025, increasing the 
burden even in high-income countries.  
We have found that high prevalence is attributed to: rapid urbanization and globalization 
of behavioral and metabolic risk factors such as unhealthy lifestyles, smoking, aging of 
population, increased average income, higher exposure to stress and lower rates of 
physical activity. 
Many people once finally diagnosed with HPT, is not always controlled to optimal levels 
and far too many people still today are unaware of their condition, even with access to 
cost-effective treatments and effective intervention programs available in urban 
communities due to the fact that they lack vital and adequate information about our times 
most common cause of morbidity and mortality. 
To be the most successful, the general rule is to have the best information. Physicians and 
HC practitioners worldwide must understand the importance of conveying accurate and 
adequate information to the public about not only pharmacological treatments to HPT but 
also about the non-pharmacological ones, such as lifestyle modifications. The most 
superior proven intervention recommendations for prevention of HPT since 1993 has 
been; weight loss, reduction of dietary sodium intake, moderation in alcohol consumption 
and increased physical activity.  
Doctor-patient communication is very important in conveying this type of information, 
how simple life style changes these individuals can make, have great impact on 
improving their BP and compliance. 
There have been improvements in the prevalence, awareness, treatment and control over 
the past decades through primary intervention programs and better management plans.  
However the ‘rule of halves’ are still valid in many urban populations today and optimal 
levels of BP is far from satisfactory, even in countries where neither medical help and/or 
treatment costs is not an issue. 
15 
 
HPT is not just an increase in BP, but it contributes to cardiovascular system and 
metabolic syndrome, thus much attention should be given to the high rates of prevalence 
and low rates of control, which are far from acceptable needing further research and 
improvements in HPT unawareness and control.  
We have during this review acknowledged some contributions to the high level of 
prevalence and low levels of awareness that can help beat back the global threat of HPT 
and its burden. 
By strengthened national surveillance programs and policies, with reliable information in 
monitoring and controlling the PH with HPT and increase the study of evidence based 
medicine in this area for better primary prevention. 
 
 Decentralization of health care 
Regulating the HC responsibilities from a central body to county level can off load the 
central and gives local governments more freedom in this area. It is important that every 
country and community understands their own local needs and find suitable solutions.  
 
 Lack of commitment in government 
WHO has acknowledged that many governments are overwhelmed by the speed of 
growth and rapidly growing urban cities and unable to keep pace with the expanding 
needs for newer policies, legislations, services and infrastructure that could help in 
overcoming CVD’s. But governments must understand that there is significant financial 
and health gains associated with early detection, adequate treatment and good control of 
compared to secondary complication preventions which would include high budget 
surgical procedures. Programs to battle the problems of urbanization and globalization of 
unhealthy lifestyles early during the development of urban areas. People in developing 
countries are increasingly eating more and more unhealthy foods with higher levels of 
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total energy as well as being targeted by tobacco, alcohol and fast food marketing while 
availability of these products increases.  
 
 Community wide changes in unhealthy behavior and risk factors  
The National High Blood Pressure Program reports challenges in the prevention of HPT. 
These are factors at different levels of the HC system but also include people with 
different cultural norms, inadequate care, attention or understanding of the importance of 
health education, lack of reimbursement for HPT prevention services by the government.  
HC professionals and policy developers must collaborate with the food industry to 
increase availability to products, which is healthier and contains less sodium. 
Higher commitment is needed to prioritize effective and wide population intervention 
approaches to reduce high BP, similar to the ones addressing other major NCD´s (since 
HPT is the leading cause of CVD’s) such as salt reduction and physical activity.  
 
 Improvements in resources and Primary prevention in PHC 
According to National High Blood Pressure Program, PHC level (with increased 
collaboration between primary care and PH) is one affordable strategy to tackle still 
today’s urban HPT unawareness and inadequate control. This way a large population can 
be reached. Unfortunately this seems to be the weakest level of the health system in many 
countries. By implementing integrated programs, systems and services in place to 
promote universal health and lead a multidisciplinary approach to support healthy 
lifestyles and to provide the population with access to adequate, good quality and cost 
effective HC and medications for management just as written in Alma Ata declaration.  
Best buys- cost-effective strategy plans and policies should be implemented especially 
where availability of healthy food is restricted, for example in poor urban areas. 
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 Better management 
Management is relatively good among industrialized countries, but lacking in many 
countries and cities with the rapid urbanization. The complexity of hospitals and HC 
systems should be studies as early as possible during the evolution of urbanization.  
Medical practitioners still needs to improve in their doctor-patient communication (as 
less than half some treated hypertensive patients are on adequate control of their BP in 
some areas) and educate them that dissatisfaction with medical care should not ever be an 
issue for a patient, making them less likely to address their health issues after a previous 
dissatisfaction with HC or GP. 
 
 Workplace health program’s to reduce risk factor related behavior 
No tolerance for tobacco smoking, support for physical activity and opportunities for 
healthy food areas. Workplace health programs have shown great success and therefore 
more focus should be given here. 
 
 Focusing on all groups and not only the traditional high-risk ones 
Among hypertensive subjects, unawareness was significantly associated with; the male 
sex (females can get detected more often due to extra checkups during pregnancy which 
can be a reason the prevalence is higher in men and the awareness lower), age (the 
common misconception that HPT only occurs in old age), less frequent visits to a HCP 
and GP (due to cultural differences or dissatisfaction with recent medical care), a high 
total cholesterol and low body weight (thinking they are healthy without knowing that the 
dangerous fat being the visceral one) , no previous family history of HPT (thus not as 
enlightened in the matter of HPT)  and smoking (which is a major risk factor) and last but 
not least, a lower level of education. 
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 Earlier detection 
Earlier screening methods, rigorous strategies should begin in childhood and adolescence 
since it provides the greatest long term potential for lowering the overall burden of 
hypertensive related complications.  
Focusing on younger men to raise the awareness of their higher prevalence and 
uncontrolled HPT. 
 
 Misconceptions and misunderstood criteria’s  
Many people go undiagnosed because it rarely causes symptoms in the early stages. 
Increasing the public awareness about the silent nature of this disease that is occurring 
without symptoms. People seem to believe the disease is only of old age and always with 
accompanied symptoms and/ or diabetes mellitus. This could be a cause why awareness 
is lower in younger age. There could be a need for re-defining criteria’s and 
standardization of BP measurements, informing about the Pathophysiology and 
mechanism increases the understanding of this disease that leads to HPT.  
 
We all have a huge role to play in the prevention, awareness and control of HPT. This 
requires will and engagement not only on the part of governments and policy- makers, 
but also in HC workers whom are the physical forms and voices of health, the academic 
research community and families and individuals. 
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new universes everyday. 
 
In loving memory of Nahida Mhedin 
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